IGC PharmaIGC +0.42%29 Days Inventory is 222.55 as of Mar. 2026, which is 56% below its 10-year median of 509.48. GuruFocus rates IGC with a GF Score™ of 29/100 and a GF Value™ of $0.24 (Fairly Valued). The stock has 6 warning signs investors should review. Among 639 Biotechnology companies, IGC Pharma ranks worse than 77.78% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). IGC Pharma's Average Total Inventories for the
three
months ended in Mar. 2026 was $0.64 Mil. IGC Pharma's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.26 Mil.
Hence, IGC Pharma's Days Inventory for the
three
months ended in Mar. 2026 was 222.55.
The historical rank and industry rank for IGC Pharma's Days Inventory or its related term are showing as below:
IGC'
s Days Inventory Range Over the Past 10 Years
Min: 26.88 Med: 509.48 Max: 8114.51
Current: 406.58
During the past 13 years, IGC Pharma's highest Days Inventory was 8114.51. The lowest was 26.88. And the median was 509.48.
IGC's Days Inventory is ranked worse than 77.78% of 639
companies
in the Biotechnology industry
Industry Median: 183.97
vs IGC: 406.58
IGC Pharma's Days Inventory
declined
from Mar. 2025 (724.04) to Mar. 2026 (222.55).
Inventory Turnover measures how fast the company turns over its inventory within a year.
IGC Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.41.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
IGC Pharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.02.
IGC Pharma (AMEX:IGC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
IGC Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
IGC Pharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
IGC Pharma Days Inventory Related Terms
IGC Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for IGC Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IGC vs CRVO, NEUP, CELU: Days Inventory Comparison
For the Biotechnology subindustry, IGC Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IGC Pharma Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IGC Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where IGC Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IGC Pharma (IGC) has a Days Inventory of 222.55 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on IGC Pharma and its competitors. This is 56% below median its historical median of 509.48. Over the past decade, IGC Pharma's Days Inventory has ranged from 26.88 to 8,114.51. According to the industry distribution chart, IGC Pharma ranks #497 out of 639 companies in the Biotechnology industry, placing it in the top 77.8%.
Is IGC Pharma's Days Inventory too high?
IGC Pharma's current Days Inventory of 222.55 is 56% below median its 10-year median of 509.48. Over the past 10 years, this metric has ranged from a low of 26.88 to a high of 8,114.51. The Biotechnology industry median Days Inventory is 183.97. IGC Pharma's value of 222.55 is 21% above this industry median. Based on the distribution chart, IGC Pharma ranks #497 out of 639 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, IGC Pharma has a GF Score™ of 29/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IGC Pharma's Days Inventory compare to CRVO and NEUP?
According to the Biotechnology industry distribution chart, IGC Pharma ranks #497 out of 639 companies for Days Inventory. This places IGC Pharma in the lower half of its industry. The industry median Days Inventory is 183.97. IGC Pharma's value of 222.55 is 21% above this benchmark. Historically, IGC Pharma's own Days Inventory has ranged from 26.88 to 8,114.51 over the past decade. While the company's 10-year median is 509.48 vs. the industry median of 183.97, IGC Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IGC Pharma's current Days Inventory of 222.55 is 21% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on IGC Pharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IGC Pharma's current Days Inventory is 222.55, which is 56% below median its own 10-year median of 509.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IGC Pharma stock overvalued right now?
Based on GuruFocus' analysis, IGC Pharma (IGC) is currently considered Fairly Valued. The stock's GF Value™ is $0.24, compared to a current price of $0.26 — trading 9.6% above its estimated fair value. The current Days Inventory is 222.55, which is 56% below median its 10-year median of 509.48 and 21% above the Biotechnology industry median of 183.97. IGC Pharma's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For IGC Pharma (IGC), the current Days Inventory is 222.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IGC Pharma (IGC) Overvalued in 2026?
Based on GuruFocus' analysis, IGC Pharma stock appears to be overvalued.
The current stock price of $0.26 is trading 9.6% above its estimated GF Value™ of $0.24.
GuruFocus considers IGC Pharma to be Fairly Valued.
Key valuation signals for IGC:
Days Inventory: 222.55 (56% below median its 10-year median of 509.48)
GF Value™: $0.24 vs. price of $0.26 (9.6% above fair value)
Industry Position: 21% above the Biotechnology median (#497 of 639)
No single metric tells the full story. See the IGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
29GF Score
Get the complete analysis for IGC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IGC has been successfully added to your 
